I thought this was going to be a non-invasive sugar-level device, but it looks like in fact the innovation here is that a popular CGM line can now do ketones?

▲

ijustlovemath 6 hours ago | parent | next [-]

non-invasive continuous blood sugar measurement is mired in patents and technical challenges. Turns out it's really difficult to disambiguate the absorption lines of glucose from other similarly shaped molecules when you're also dealing with untangling skin conductivity, transmissivity, sweat, inflammation etc.

▲

johen8 6 hours ago | parent [-]

I also think there's no financial incentive from incumbents to develop something like this. Why would abbott develop something that works "forever" if they can milk people buying new sensors every 10~14 days.

▲

cogman10 6 hours ago | parent [-]

For abbott, no. But what about for Garmin, Apple, Samsung, or Google?

Diabetics would snap up a smart watch which does accurate glucose monitoring in a heartbeat.

▲

ijustlovemath 5 hours ago | parent | next [-]

There is a major IP holder in the space who is asserting their ownership, so even if they could solve the technical challenges, they might not be able to come to market.

	▲	nomel 5 hours ago \| parent [-]
		> There is a major IP holder in the space who is asserting their ownership, Is it a secret? Why not name them?

▲

petepete 5 hours ago | parent | prev [-]

As a T1 diabetic, can confirm.

▲

jakefromstatecs 6 hours ago | parent | prev [-]

Seems to be the case, yeah